# OnCo record sokal-elts-scores (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/sokal-elts-scores/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "sokal-elts-scores" ;
  schema:name "Sokal and ELTS risk scores (chronic myeloid leukaemia)"@en ;
  schema:alternateName "Sokal"@en, "Sokal score"@en, "Sokal risk"@en, "ELTS"@en, "ELTS score"@en, "EUTOS long-term survival score"@en, "EUTOS score"@en, "Hasford score"@en, "Euro score"@en, "CML risk score"@en, "CML risk group"@en ;
  schema:description "Sokal and ELTS are arithmetic from the first blood count: age, spleen size, platelets and blast percentage at diagnosis sort chronic myeloid leukaemia into low, intermediate and high risk, and high-risk patients are the ones more likely to be started on a second-generation drug rather than imatinib."@en ;
  schema:url <https://onco.cc/terms/sokal-elts-scores/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:related <https://onco.cc/terms/philadelphia-chromosome/>, <https://onco.cc/terms/molecular-response/>, <https://onco.cc/terms/blasts/>, <https://onco.cc/drugs/imatinib/>, <https://onco.cc/drugs/nilotinib/>, <https://onco.cc/drugs/dasatinib/>, <https://onco.cc/drugs/bosutinib/>, <https://onco.cc/drugs/asciminib/>, <https://onco.cc/terms/abl1-kinase-domain-mutations/> ;
  onco:cancers <https://onco.cc/cancers/cml/>, <https://onco.cc/cancers/cml-chronic-phase/> .